| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1992PNAS...89..905A |
| P356 | DOI | 10.1073/PNAS.89.3.905 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC48353 |
| https://europepmc.org/articles/PMC48353?pdf=render | ||
| P932 | PMC publication ID | 48353 |
| P698 | PubMed publication ID | 1371012 |
| P5875 | ResearchGate publication ID | 21784724 |
| P2093 | author name string | G. Klein | |
| I. Ernberg | |||
| J. Minarovits | |||
| L. F. Hu | |||
| B. Contreras-Brodin | |||
| E. Altiok | |||
| P2860 | cites work | Epstein-Barr virus-transformed pro-B cells are prone to illegitimate recombination between the switch region of the mu chain gene and other chromosomes | Q34298046 |
| Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes | Q34299744 | ||
| Novel downstream elements upregulate transcription initiated from an Epstein-Barr virus latent promoter | Q35920295 | ||
| Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region | Q36682729 | ||
| Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids | Q36828590 | ||
| 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael | Q36829470 | ||
| Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection | Q37504372 | ||
| Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site | Q37552683 | ||
| Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes | Q37707304 | ||
| The Epstein-Barr virus proteins | Q39216150 | ||
| Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene | Q40062679 | ||
| Host cell phenotype-dependent methylation patterns of Epstein--Barr virus DNA | Q41678227 | ||
| Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line | Q41729284 | ||
| Extinction of an immunoglobulin kappa promoter in cell hybrids is mediated by the octamer motif and correlates with suppression of Oct-2 expression | Q41734568 | ||
| The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus | Q42813897 | ||
| Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance | Q42818302 | ||
| Identification of the 37-kDa protein displaying a variable interaction with the erythroid cell membrane as glyceraldehyde-3-phosphate dehydrogenase | Q43682701 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| phenotype | Q104053 | ||
| promoter | Q224093 | ||
| viral gene expression regulation | Q70682269 | ||
| P304 | page(s) | 905-909 | |
| P577 | publication date | 1992-02-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6 | |
| P478 | volume | 89 |
| Q35839956 | A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. |
| Q40441060 | Analysis of Viral Promoter Usage in EBV-Infected Cell Lines: A Comparison of qPCR Following Conventional RNA Isolation and Nuclear Run-On Assay |
| Q33843046 | BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186. |
| Q39165552 | Characterization of EBV Promoters and Coding Regions by Sequencing PCR-Amplified DNA Fragments |
| Q40020928 | Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency |
| Q40889854 | De novo DNA methylation at nonrandom founder sites 5' from an unmethylated minimal origin of DNA replication in latent Epstein-Barr virus genomes |
| Q39685900 | Deletion of Epstein-Barr virus regulatory sequences upstream of the EBNA gene promoter Wp1 is unfavorable for B-Cell immortalization |
| Q39596964 | Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals. |
| Q35784734 | EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells |
| Q36164746 | Epigenetic regulation of lymphoid specific gene sets |
| Q43639212 | Epigenetics of latent Epstein-Barr virus genomes: high resolution methylation analysis of the bidirectional promoter region of latent membrane protein 1 and 2B genes |
| Q34576340 | Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions |
| Q39607885 | Epstein-Barr virus nuclear antigen 5 inhibits pre-mRNA cleavage and polyadenylation |
| Q39868924 | Expression of cyclin D2 in Epstein-Barr virus-positive Burkitt's lymphoma cell lines is related to methylation status of the gene |
| Q45722276 | High-resolution methylation analysis and in vivo protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes |
| Q34273467 | Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation |
| Q36564877 | Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs |
| Q33957851 | Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency |
| Q34161866 | Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells |
| Q39585366 | Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation |
| Q33865166 | Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus |
| Q37146126 | Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases |
| Q39579096 | Specific methylation patterns in two control regions of Epstein-Barr virus latency: the LMP-1-coding upstream regulatory region and an origin of DNA replication (oriP). |
| Q33783746 | The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive |
Search more.